OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.

Registration to our newsletter is FREE, Join today by entering your email below!

Tag Archives: fda approval

Can Dynavax Technologies Corp. (NASDAQ: DVAX) Overcome FDA Setback for HEPLISAV?

Posted on November 16, 2012 by Editor

Shares of Dynavax Technologies Corp. (NASDAQ: DVAX) have been getting pounded on Friday following yesterday’s announcement that their lead product candidate HEPLISAV, an adult hepatitis B vaccine, failed to gain the support of an FDA advisory committee concerning safety issues. … Continue reading →

Posted in Articles, NASDAQ | Tagged , , , , , , , , , | Leave a comment

Is Talon Therapeutics (OTCBB: TLON) Worth the Investment Even with an FDA Approval?

Posted on August 1, 2012 by Editor

After hitting a high of 1.83 just two days ago shares of Talon Therapeutics (OTCBB: TLON) have come crashing down, sinking as low as 0.81 on Wednesday and the bleeding may just be getting started. While TLON is less than … Continue reading →

Posted in Uncategorized | Tagged , , , , , , , , | Leave a comment

Viral Genetics Inc. (PINKSHEETS: VRAL) Trying to Manage Massive Deficit While Promoting Advancements in Biotechnology Pipeline

Posted on March 7, 2012 by Editor

It was almost a year ago that Viral Genetics Inc. (PINKSHEETS: VRAL) was trading at a 52-week high of 0.0490 but eleven months later the small biotechnology company’s shares were at a 52-week low of 0.0090 with an accumulated deficit … Continue reading →

Posted in Uncategorized | Tagged , , , , , , , , , | Leave a comment

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) Receives Patent Allowance but FDA Approval for BEMA Buprenorphine Remains Critical

Posted on February 17, 2012 by Editor

Less than two months ago shares of BioDelivery Sciences International, Inc. (NASDAQ: BDSI) were trading at a 52-week low of 0.77 but the fortunes of the specialty pharmaceutical company that develops novel and proprietary patented drug delivery technologies has changed … Continue reading →

Posted in Articles, NASDAQ | Tagged , , , , , , | Leave a comment

Allezoe Medical Holdings, Inc. (OTCBB: ALZM) Acquires Diagnostic Technology for HPV but FDA Approval Remains a Hurdle Yet to be Cleared

Posted on December 21, 2011 by Editor

With Allezoe Medical Holdings, Inc. (OTCBB: ALZM) announcing on Tuesday that they had acquired the exclusive license to develop and market patent pending, advanced “see and treat” diagnostic technology for Human papillomavirus (HPV), the world’s leading sexually transmitted infection, trading … Continue reading →

Posted in Uncategorized | Tagged , , , , , , , , , , | Leave a comment

Alexza Pharmaceuticals (NASDAQ: ALXA) Gaining Momentum on FDA Approval Recommendation Regarding ADASUVE

Posted on December 13, 2011 by Editor

Following news that Alexza Pharmaceuticals (NASDAQ: ALXA) received recommendation for FDA approval from the Psychopharmacologic Drugs Advisory Committee (PDAC) of the U.S. Food and Drug Administration (FDA) relating to their schizophrenia and bipolar mania treatment ADASUVE shares in the pharmaceutical … Continue reading →

Posted in Articles, NASDAQ | Tagged , , , , , , , , , , | Leave a comment

Is Cell Therapeutics, Inc. (NASDAQ: CTIC) Any Closer to FDA Approval for non-Hodgkin’s Lymphoma Drug Pixantrone?

Posted on December 1, 2011 by Editor

The road to FDA approval for Cell Therapeutics, Inc. (NASDAQ: CTIC) has been one littered with speed bumps and potholes yet the biotechnology company now sits just a few months away from potentially clearing the final hurdle and advancing their … Continue reading →

Posted in Articles, NASDAQ, Penny Stocks | Tagged , , , , , , , , | Leave a comment

Allezoe Medical Holdings, Inc. (OTCBB: ALZM) Finding it Hard to Convince Investors about HPV Technology while LifeCradle Technology Remains on Life Support

Posted on October 7, 2011 by Editor

Investors that are considering taking a position in Allezoe Medical Holdings, Inc. (OTCBB: ALZM) based on their recent announcements detailing their agreement to acquire patent pending technology that would enable healthcare providers to “see and treat” Human Papillomavirus (HPV) and … Continue reading →

Posted in Uncategorized | Tagged , , , , , , , , , , | Leave a comment

Will Questions Concerning Benefit-Risk Slow FDA Approval of Seattle Genetics (NASDAQ: SGEN) Cancer Drug Adcetris?

Posted on July 13, 2011 by Editor

After 14 long years it looks as if Seattle Genetics (NASDAQ: SGEN) is now less than two months away from receiving its first FDA approval. Having taken a giant step on Tuesday following a relatively benign overview offered by the … Continue reading →

Posted in Articles, NASDAQ | Tagged , , , , , , , , , | Leave a comment

BrainStorm Cell Therapeutics (OTCBB: BCLI) Share Price and Volume Jump on Research Analyst Report Despite Absence of Revenue and Products

Posted on June 24, 2011 by Editor

Take a company like BrainStorm Cell Therapeutics (OTCBB: BCLI), which has been trading around the 0.25 – 0.30 with minimal volume over the past several months, throw in a “Buy” recommendation from a research analyst that predicts share price to … Continue reading →

Posted in Articles, OTC Bulletin Board, Penny Stocks | Tagged , , , , , , , , , , , | Leave a comment